Crynodeb
Transgenic plants are showing considerable potential for the economic production of proteins, with a few already being marketed. Recent clinical trials of pharmaceuticals produced from transgenic plants are encouraging, with plant glycans showing reassuringly poor immunogenicity. Our increasing understanding of protein targeting and accumulation should further improve the potential of this new technology.
| Iaith wreiddiol | Saesneg |
|---|---|
| Tudalennau (o-i) | 450-454 |
| Nifer y tudalennau | 5 |
| Cyfnodolyn | Current Opinion in Biotechnology |
| Cyfrol | 12 |
| Rhif cyhoeddi | 5 |
| Dynodwyr Gwrthrych Digidol (DOIs) | |
| Statws | Cyhoeddwyd - 01 Hyd 2001 |
Ôl bys
Gweld gwybodaeth am bynciau ymchwil 'Transgenic plants as protein factories'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.Dyfynnu hyn
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver